TrialEuropean journal of haematology2012

High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy.

Sari Riihijärvi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.